Key statistics
On Friday, ONWARD Medical NV (63E:STU) closed at 4.87, -23.43% below its 52-week high of 6.36, set on Feb 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.87 |
---|---|
High | 4.87 |
Low | 4.87 |
Bid | 4.97 |
Offer | 5.22 |
Previous close | 4.80 |
Average volume | 997.80 |
---|---|
Shares outstanding | 44.63m |
Free float | 33.70m |
P/E (TTM) | -- |
Market cap | 228.50m EUR |
EPS (TTM) | -1.09 EUR |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024
- ONWARD® Medical Publishes Closing of Bookbuild Offering
- ONWARD® Medical Publishes Prospectus for Listing of New Shares
- ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
- ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA
- ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA
- ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
- ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
- ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
- ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
More ▼